Sanofi chief says U.S. Supreme Court ruling on biologics has "immediate impact"

PARIS (Reuters) - The U.S Supreme Court decision to speed access to copycat biologics drugs on Monday was expected but has an "immediate impact", Sanofi Chief Executive told Reuters.